89 related articles for article (PubMed ID: 8673095)
1. Breast cancer susceptibility testing: realities in the post-genomic era.
Friend SH
Nat Genet; 1996 May; 13(1):16-7. PubMed ID: 8673095
[No Abstract] [Full Text] [Related]
2. [BRCA1 and BRCA2--breast cancer susceptibility genes].
Dagan E; Gershoni-Baruch R
Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320
[No Abstract] [Full Text] [Related]
3. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility to breast and ovarian cancer.
Skolnick MH; Frank T; Shattuck-Eidens D; Tavtigian S
Pathol Biol (Paris); 1997 Mar; 45(3):245-9. PubMed ID: 9296070
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
7. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
8. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Kuschel B; Lux MP; Goecke TO; Beckmann MW
Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
[TBL] [Abstract][Full Text] [Related]
9. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
Ost E; Illiger HJ
Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
[No Abstract] [Full Text] [Related]
10. [A genetic test for breast cancer: curse or blessing?].
Sauer H
Fortschr Med; 1995 Feb; 113(4):9-10. PubMed ID: 7713472
[No Abstract] [Full Text] [Related]
11. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.
Díez O; Osorio A; Robledo M; Barroso A; Domènech M; Cortés J; Albertos J; Sanz J; Brunet J; SanRomán JM; Alonso MC; Baiget M; Benítez J
Br J Cancer; 1999 Mar; 79(7-8):1302-3. PubMed ID: 10098775
[TBL] [Abstract][Full Text] [Related]
12. Inherited predisposition to breast cancer.
Ponder BA
Biochem Soc Symp; 1998; 63():223-30. PubMed ID: 9513726
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition testing for breast cancer.
Audeh MW
Cancer J Sci Am; 1997; 3(4):254-5. PubMed ID: 9263632
[No Abstract] [Full Text] [Related]
14. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
[TBL] [Abstract][Full Text] [Related]
15. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
16. Are local recurrences after breast conserving therapy more frequent in patients with BRCA1/BRCA2 mutations?
Kurtz JM
Strahlenther Onkol; 2000 Sep; 176(9):433-4. PubMed ID: 11050918
[No Abstract] [Full Text] [Related]
17. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
[TBL] [Abstract][Full Text] [Related]
18. Genetic developments in breast cancer.
Favors AC
J Insur Med; 1995-1996 Winter; 27(3):214-9. PubMed ID: 10161380
[TBL] [Abstract][Full Text] [Related]
19. BRCA1. A new marker in the management of patients with breast cancer?
Offit K
Cancer; 1996 Feb; 77(4):599-601. PubMed ID: 8616748
[No Abstract] [Full Text] [Related]
20. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
